MarketPeel
Insider Trading Intelligence
LR

Leonard Reyno

CCCC
CHIEF MEDICAL OFFICER · C4 THERAPEUTICS, INC. · CIK 0001528716
FILING MIX · LIFETIME54%/46%
BUYS
7
SELLS
6
TOTAL VALUE
$130.2K
COMPANIES
1
ACTIVE SINCE
Feb 2024
HOLDINGS NOW
379,803
AVG SELL PX
$2.47
TRADE KIND
SHOWING 13 / 13
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Leonard Reyno, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-3.59%-0.35%-3.24%-3.24%
14d1+100.00%-14.80%+0.04%-14.84%-14.84%
30d1+100.00%-15.25%-1.43%-13.81%-13.81%
60d1+0.00%+23.77%-3.02%+26.78%+26.78%
90d1+0.00%+30.05%+1.45%+28.60%+28.60%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CCCC · 379,803 shares · as of Feb 14, 2026
099,096198,191297,287396,38220252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 7 buys / 6 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CCCC
C4 THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
30,950396,382Feb 14, 2026Feb 18, 2026View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
16,579$1.89$31.3K379,803Feb 14, 2026Feb 18, 2026View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
240,000396,382Feb 13, 2026Feb 18, 2026View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
10,000$2.22$22.2K156,382Jan 16, 2026Jan 16, 2026View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
7,382$1.99$14.7K166,382Jul 10, 2025Jul 14, 2025View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASE
Chief Medical Officer
15,325173,764Jul 10, 2025Jul 15, 2025View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
7,382$1.99$14.7K166,382Jul 10, 2025Jul 15, 2025View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
5,145$3.18$16.4K173,764Feb 14, 2025Feb 18, 2025View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
130,600130,600Feb 14, 2025Feb 18, 2025View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
87,100178,909Feb 14, 2025Feb 18, 2025View →
CCCC
C4 THERAPEUTICS, INC.
SALE
Chief Medical Officer
6,191$5.00$31.0K91,809Jul 10, 2024Jul 11, 2024View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
165,300165,300Feb 14, 2024Feb 15, 2024View →
CCCC
C4 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
36,70098,000Feb 14, 2024Feb 15, 2024View →
Other insiders · CCCC
Loading peer insiders…
About this filer
CIK 0001528716
ROLE
Chief Medical Officer
PRIMARY
CCCC
COMPANIES
1
ACTIVE SINCE
Feb 2024
MARKETPEEL · /INSIDER/0001528716DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback